Alberto Bardelli, a molecular geneticist and expert in the field of personalized therapies, directs the IFOM Genomics of Cancer and Targeted Therapies program at the Institute for Cancer Research and Treatment in Candiolo, near Turin. Bardelli studied Biological Sciences at the University of Turin, graduating cum laude in 1991 and an honourable mention. After graduation he moved to the Ludwig Institute for Cancer Research in London were he obtained a Ph.D. in Biochemistry and Molecular biology from the University College London (UCL), in 1996. He returned briefly to Turin to conduct research at the Institute for Cancer Research and Treatment, before moving to the United States in 1999 for a post-doctoral fellowship in the laboratory directed by Bert Vogelstein at the Howard Hughes Medical Institute at the Johns Hopkins University in Baltimore. Here Bardelli began studying the genetics of cancer. During his postdoctoral training at the Johns Hopkins, Bardelli published multiple papers in high profile journals such as Nature, Science and PNAS. In 2004 he decided to return to Italy. The opportunity to create a research unit dedicated to the study of tumor genomes and to transfer the findings to clinical practice came in two different centers at once: The Institute for Cancer Research and Treatment in Candiolo and the IFOM in Milan. Since 2005 Bardelli has also held an Associate Professorship at the Dept. of Oncology, Medical School, University of Turin.